CS228923B2 - Method of preparing 4-oxo-pgi2 and analogues thereof - Google Patents

Method of preparing 4-oxo-pgi2 and analogues thereof Download PDF

Info

Publication number
CS228923B2
CS228923B2 CS822662A CS266282A CS228923B2 CS 228923 B2 CS228923 B2 CS 228923B2 CS 822662 A CS822662 A CS 822662A CS 266282 A CS266282 A CS 266282A CS 228923 B2 CS228923 B2 CS 228923B2
Authority
CS
Czechoslovakia
Prior art keywords
alkyl
oxo
formula
substituted
phenyl
Prior art date
Application number
CS822662A
Other languages
Czech (cs)
English (en)
Inventor
Geza Galambos
Vilmos Dr Simonidesz
Jozsef Ivanics
Istvan Dr Szekely
Krisztina Kekesi
Gabor Dr Kovacs
Istvan Dr Stadler
Peter Koermoezy
Karoly Horvath
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CS228923B2 publication Critical patent/CS228923B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
CS822662A 1981-04-14 1982-04-14 Method of preparing 4-oxo-pgi2 and analogues thereof CS228923B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU81966A HU184949B (en) 1981-04-14 1981-04-14 Process for preparing 4-oxo-pgi down 2 and analogues thereof

Publications (1)

Publication Number Publication Date
CS228923B2 true CS228923B2 (en) 1984-05-14

Family

ID=10952245

Family Applications (1)

Application Number Title Priority Date Filing Date
CS822662A CS228923B2 (en) 1981-04-14 1982-04-14 Method of preparing 4-oxo-pgi2 and analogues thereof

Country Status (14)

Country Link
US (1) US4438132A (hu)
EP (1) EP0063338B1 (hu)
JP (1) JPS57179178A (hu)
AT (1) ATA139182A (hu)
CS (1) CS228923B2 (hu)
DD (1) DD202559A5 (hu)
DE (1) DE3262285D1 (hu)
DK (1) DK165382A (hu)
FI (1) FI821282L (hu)
GR (1) GR76128B (hu)
HU (1) HU184949B (hu)
IL (1) IL65491A (hu)
PL (1) PL235963A1 (hu)
SU (1) SU1128834A3 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184948B (en) * 1981-04-14 1984-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 5-substituted 4-oxo-pgi down 1 derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126744A (en) * 1977-12-05 1978-11-21 The Upjohn Company 4-Oxo-PGI1 compounds
JPS54115368A (en) * 1978-03-01 1979-09-07 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition containing it as active constituent

Also Published As

Publication number Publication date
FI821282A0 (fi) 1982-04-13
ATA139182A (de) 1986-03-15
DD202559A5 (de) 1983-09-21
HU184949B (en) 1984-11-28
DE3262285D1 (en) 1985-03-28
EP0063338A1 (de) 1982-10-27
DK165382A (da) 1982-10-15
IL65491A (en) 1986-01-31
IL65491A0 (en) 1982-07-30
FI821282L (fi) 1982-10-15
SU1128834A3 (ru) 1984-12-07
EP0063338B1 (de) 1985-02-13
JPS57179178A (en) 1982-11-04
GR76128B (hu) 1984-08-03
US4438132A (en) 1984-03-20
PL235963A1 (en) 1983-07-04

Similar Documents

Publication Publication Date Title
US5004752A (en) Novel 9-haloprostaglandins, processes for their preparation, and their use as medicinal agents
US4552875A (en) Novel carbacyclinamides, their preparation and use as medicinal agents
HU187466B (en) Process for producing new 5-cyano-prostacycline derivatives and pharmaceutical compositions containing them
US4285966A (en) Certain 15-epi-prostacyclins
HU190007B (en) Process for producing new aromatic prostacylin analogues
CS228923B2 (en) Method of preparing 4-oxo-pgi2 and analogues thereof
US4330553A (en) 7-Oxo-PGI2 -derivatives and process for the preparation thereof and pharmaceutical compositions containing same
JPS60161967A (ja) イオウ含有６‐ケトプロスタクランジン化合物
EP0338796B1 (en) 2-substituted-2-cyclopentenones
KR850000388B1 (ko) 복소환 화합물 및 이의 이성체의 제조방법
CA1246557A (en) Carbacyclin esters, process for their manufacture and their use as medicaments
JPS6228788B2 (hu)
JPH0451537B2 (hu)
US3931285A (en) Substituted tolyl esters of PGE1
US3998869A (en) Substituted anilide esters of 16-substituted PGE2
US4740523A (en) Interfuranylene prostacyclins
EP0063323B1 (de) 5-Substituierte 4-Oxo-PGI1-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Präparate
US3994956A (en) Substituted anilide esters of 16-phenoxy and 17-phenyl PGE2 type compounds
US4828763A (en) Therapeutically active derivatives of ursodeoxycholic acid and process for preparing the same
DD202429A5 (de) Verfahren zur herstellung neuer prostaglandine und prostacycline
US4425358A (en) 13-Thia-prostacycline derivatives
US4379164A (en) Vasodilative 4-thia-PGI1 and 4-sulfinyl-PGI1 and derivatives thereof
JPH0222071B2 (hu)
US4588713A (en) Selective biologically active 7-oxo-prostacyclin derivatives and pharmaceutical compositions containing same
FI82690B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 7-oxo-pg12-efedrinsalter.